Navigation Links
Sealant in Medical News

Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products

HAE:TSX Haemacure Completes US$2.5 Million Bridge Financing from Angiotech MONTREAL, June 3 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company, announces that Haemacure and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , T...

CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS)

LAS VEGAS, May 21 /PRNewswire-FirstCall/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF.OB), announced today the filing of its first patent of a synthetic sealant for specific application to the MedClose(TM) VCS. CPC is focused on the development and testing of the MedClose(TM) VCS, which is a...

Haemacure's Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury

HAE:TSX Skin graft fixation for burn victims using fibrin sealant represents multi-million dollar market opportunity for Company MONTREAL, Dec. 9 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company developing high-valu...

Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model

HAE:TSX MONTREAL, Sept. 11 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, disclosed today the positive results of a second preclinical study con...

Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need

HAE:TSX MONTREAL, April 10 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, disclosed today the results of a preclin...

Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials

HAE:TSX MONTREAL, Oct. 24 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company, is pleased to announce a new two-phase strategy to have a first patient undergo surgery in the pivotal clinical trials for ...

NeoMend Receives FDA Panel's Recommendation for Approval of ProGEL(TM) Surgical Sealant

IRVINE, Calif., June 17 /PRNewswire/ -- NeoMend, Inc. today announced that its ProGEL(TM) Surgical Sealant has received a recommendation for approval from the U.S. Food and Drug Administration's (FDA) Anesthesiology and Respiratory Therapy Devices Advisory Panel. The panel's recommendation w...

Tenaxis Medical Inc. Announces First Human Use of Vascular Sealant

Tenaxis Medical, Inc., a medical device company founded in 2004 to bring high performance surgical sealants to the vascular and general surgical markets, announced that vascular surgeons at the Krankenhaus Friedrichstadt in Dresden, Germany were the first to clinically use their novel high perform...

FDA Approves Expanded Use for Surgical Sealant

The U.S. Food and Drug Administration (FDA) today approved Evicel Fibrin Sealant, a liquid product that when applied topically helps control oozing from small blood vessels during surgical procedures. "Evicel provides an effective means to stop oozing from small vessels during vascular sur...

Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals, Inc. and Second Quarter 2009 Financial Results

...ply rights related to Haemacure's all-human fibrin sealant and thrombin products, both of which are currently... to complete the development and launch our fibrin sealant and thrombin products on the market, said Joseph G...exclusively derived from the sale of legacy fibrin sealant application devices. Operating expenses amounted t...
Sealant in Medical Technology

Bayer Issues Additional Guidance to Physicians on Trasylol(R)

...indicated in patients with a known or suspected aprotinin exposure during the last 12 months. Aprotinin may also be a component of some fibrin sealant products. -- In clinical studies, hypersensitivity and anaphylactic reactions were rare ( Trasylol administration increases the risk for renal dysfu...

FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)

...s contraindicated in patients with a known or suspected aprotinin exposure during the last 12 months. Aprotinin may also be a component of some fibrin sealant products. -- In clinical studies, hypersensitivity and anaphylactic reactions were rare ( Trasylol(R) administration increases the risk for renal d...

Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery

...arate study presented at SABM finds EVICEL* Fibrin sealant (Human) more effective than manual compression ...e of treatment failures was observed in the fibrin sealant group. The results of this study suggest that EVIC...en and is currently the only aprotinin-free fibrin sealant commercially available in the U.S. EVITHROM* and ...

Haemacure Announces Preliminary Findings of its Plasma Discard Analysis

...and enzymes will constitute a direct contribution to the bottom line. This is because the cost of the plasma will be fully borne by Haemacure's fibrin sealant and hemostatic agent once these products will be commercialized. "We are very excited with the positive outcome of the content analysis of one of ou...
Sealant in Medical Products

DuraSeal Dural Sealant

Description: The DuraSeal System includes an innovative polyethylene glycol hydrogel sealant and applicator packaged in a single-use kit which can be stored at room temperature for convenience and quick preparation....
Company:Confluent Surgical

COSEAL Surgical Sealant

Description: The two distinct polyethylene glycol polymers that combine to form COSEAL Surgical Sealant have the unique ability to chemically bond to each other, as well as to tissue surfaces. The fully biocompatible synthetic material forms a flexible, watertight seal that remains intact at the site and is abl...
Company:Baxter Healthcare

TISSEEL VH Fibrin Sealant

Description: TISSEEL VH Fibrin Sealant has been shown to be a highly effective adjunct in surgical repair. Containing uniform, reproducible concentrations of fibrinogen and thrombin, TISSEEL VH Fibrin Sealant simulates the final stage of the coagulation cascade to produce a biocompatible fibrin matrix clot that...
Company:Baxter Healthcare

CROSSEAL*

Description:... CROSSEAL* Fibrin sealant (Human) achieves a secure clot, targeted to the area of the liver where sup...re, ligature, and cautery, is ineffective or impractical. CROSSEAL* Fibrin sealant (Human) delivers a unique formulation of human Biologically Active Componen...
Company:Ethicon, Inc.

Hemaseel APR

Description:... Hemaseel APR a two-component fibrin sealant vapor heated kit, which is the first commercially available fibrin sealant in the United States. Fibrin sealants are used for two specific reasons: to...
Company:Haemacure Corporation
Sealant in Biological News

Chemical 'band-aid' prevents heart failure in mice with muscular dystrophy

... failure caused by cardiomyopathy, a gradual weakening of the heart muscle. Heart failure is the second leading cause of death in DMD. The chemical sealant that protected hearts in dystrophic mice from damage is called poloxamer 188. According to Joseph M. Metzger, Ph.D., the U-M scientist who directed th...
Sealant in Biological Technology

Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients

Biologically active tissue adhesive allows for placement of skin grafts without staples or sutures DEERFIELD, Ill., March 20 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation announced today the U.S. Food and Drug Administration (FDA) approval of ARTISS (Fibrin Seal...

EVICEL(TM) Fibrin Sealant (Human) Approved for General Hemostasis in Surgery

Indication positions EVICEL(TM) as the only aprotinin-free fibrin sealant option for a broad range of surgical procedures. SOMERVILLE, N.J., Jan. 10 /PRNewswire/ -- ETHICON, INC. announced today that the U.S. Food and Drug Administration has granted an expanded indication for EVICEL(...

Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation

...the following three agreements: - Fibrin sealant Distribution Agreement. The parties have entered i...rld-wide distribution rights to Haemacure's fibrin sealant product candidate in selected surgical indi... to certain performance adjustments. Any fibrin sealant product would be marketed and distributed b...

Johnson & Johnson Announces Definitive Agreement to Acquire Omrix

...ETHICON currently has exclusive distribution rights in the U.S. and the European Union for EVITHROM(TM) Thrombin Topical (Human) and EVICEL(TM) Fibrin sealant (Human), two active, biologic-based hemostats manufactured by Omrix. ETHICON and Omrix are also partnering on a Fibrin Pad product candidate, current...

CPC of America Announces Agreement with BC Tech for Manufacture of MedClose(TM) Vascular Closure System

...h will manufacture the MedClose(TM) vascular closure system (VCS), a Class II extravascular puncture-closure device that may be used with a biological sealant for worldwide commercial application in diagnostic and interventional cardiovascular procedures. The Company aims to fill a global market need for a s...

CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label

...al bleeding, making it the perfect complement to CryoLife's BioGlue(R) product line, which is much stronger and provides both tissue reinforcement and sealant capabilities," stated Steven G. Anderson, president and chief executive officer. "Hemostase MPH also allows us to compete in the surgical hemostat mar...

Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook

... -- U.S. Food and Drug Administration (FDA) approval of ARTISS [Fibrin sealant (Human)], the first and only slow-setting fibrin sealant indicated for use in adhering skin grafts in adult and pediatric burn ...
Other Tags
(Date:5/29/2015)... 29, 2015 Wimbledon Health Partners, the ... (EKG), echocardiogram and NCV testing, is proud to ... for EKG interpretation of athletes. , ... death during athletic activity. New findings presented in February ... to improve cardiac safety in athletes. Physiologic adaptations in ...
(Date:5/29/2015)... 29, 2015 Thursday, May 21st was the ... from all walks of life came together to raise money ... Day is a campaign dedicated to raising money for children ... and making people laugh, the people at Hands-On Seminars decided ... Here they provided food, fun and laughter to their ...
(Date:5/29/2015)... 2015 Belviq for weight loss ... prescription diet medication. In 2012, the FDA approved ... have a BMI >30. It is also approved ... one additional weight-related health condition such as high blood ... main function for weight loss focuses on the brain’s ...
(Date:5/28/2015)... External Counterpulsation (EECP/ECP) has been used ... United States. There are a growing number of people ... symptoms of angina and these patients are often times ... surgery. , “No option” patients are a sizable cohort ... that is considered unacceptable for heart stent or bypass. ...
(Date:5/28/2015)... May 28, 2015 AMVETS National Executive ... the Commission on Care established by Congress to examine ... veterans. , Appointed to the commission by Mitch McConnell, ... be one of only 15 voting members on the ... and Accountability Act of 2014. The goal of the ...
Breaking Medicine News(10 mins):Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 3Health News:Groups, such as Hands-On Physical Therapy, Across the Country, Host Their Own Events and Make the Inaugural Red Nose Day a Huge Success 2Health News:Belviq for Weight Loss is Now Available to Qualified Diet Doc Patients Nationwide 2Health News:Belviq for Weight Loss is Now Available to Qualified Diet Doc Patients Nationwide 3Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2Health News:AMVETS Executive Director Stewart Hickey Appointed to Congressional Commission on Care 2
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, reminds investors and ... Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, ... 2015. The three-day conference is organized into ... speaking in is themed Global Fraud: Where is the ...
(Date:4/21/2015)... High crime rate, increasing ... access control systems market in Saudi Arabia ... published report by TechSci Research " Saudi Arabia Access Control ... systems market in Saudi Arabia ... control systems market in the Kingdom is growing at ...
(Date:4/14/2015)...  HYPR Corp. today announced it has joined ... tm , an industry consortium transforming online authentication ... technology and collaborate to deliver open specifications for ... and private, and easier to use. ... sensitive user information and eliminates the dependency on ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
Other Contents